annual CFI:
-$2.41B+$804.67M(+25.03%)Summary
- As of today (May 29, 2025), TAK annual cash flow from investing activities is -$2.41 billion, with the most recent change of +$804.67 million (+25.03%) on March 1, 2025.
- During the last 3 years, TAK annual CFI has fallen by -$645.01 million (-36.55%).
- TAK annual CFI is now -164.92% below its all-time high of $3.71 billion, reached on March 31, 2021.
Performance
TAK Cash from investing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly CFI:
-$132.38M+$584.34M(+81.53%)Summary
- As of today (May 29, 2025), TAK quarterly cash flow from investing activities is -$132.38 million, with the most recent change of +$584.34 million (+81.53%) on March 1, 2025.
- Over the past year, TAK quarterly CFI has increased by +$356.97 million (+72.95%).
- TAK quarterly CFI is now -103.83% below its all-time high of $3.46 billion, reached on September 30, 2019.
Performance
TAK quarterly CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM CFI:
-$2.41B+$356.97M(+12.90%)Summary
- As of today (May 29, 2025), TAK TTM cash flow from investing activities is -$2.41 billion, with the most recent change of +$356.97 million (+12.90%) on March 1, 2025.
- Over the past year, TAK TTM CFI has increased by +$804.67 million (+25.03%).
- TAK TTM CFI is now -164.92% below its all-time high of $3.71 billion, reached on March 31, 2021.
Performance
TAK TTM CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash from investing Formula
CFI = Cash Inflows from Investments − Cash Outflows for Investments
TAK Cash from investing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +25.0% | +73.0% | +25.0% |
| 3 y3 years | -36.5% | +46.5% | -36.5% |
| 5 y5 years | -189.7% | -139.6% | -189.7% |
TAK Cash from investing Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -36.5% | +46.4% | at high | +96.0% | -67.0% | +60.0% |
| 5 y | 5-year | -164.9% | +46.4% | -104.8% | +96.0% | -164.9% | +60.0% |
| alltime | all time | -164.9% | +90.6% | -103.8% | +99.1% | -164.9% | +90.7% |
TAK Cash from investing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2025 | -$2.41B(-25.0%) | -$132.38M(-81.5%) | -$2.41B(-12.9%) |
| Dec 2024 | - | -$716.72M(+29.0%) | -$2.77B(+10.2%) |
| Sep 2024 | - | -$555.58M(-44.7%) | -$2.51B(+10.2%) |
| Jun 2024 | - | -$1.01B(+105.4%) | -$2.28B(-29.2%) |
| Mar 2024 | -$3.21B(-28.5%) | -$489.35M(+6.2%) | -$3.21B(-46.6%) |
| Dec 2023 | - | -$460.58M(+42.9%) | -$6.03B(+2.5%) |
| Sep 2023 | - | -$322.20M(-83.4%) | -$5.88B(+3.0%) |
| Jun 2023 | - | -$1.94B(-41.1%) | -$5.71B(+26.9%) |
| Mar 2023 | -$4.50B(+154.8%) | -$3.30B(+952.9%) | -$4.50B(+211.5%) |
| Dec 2022 | - | -$313.42M(+106.7%) | -$1.44B(-15.5%) |
| Sep 2022 | - | -$151.60M(-79.3%) | -$1.71B(-7.8%) |
| Jun 2022 | - | -$730.96M(+195.4%) | -$1.85B(+5.0%) |
| Mar 2022 | -$1.76B(-147.5%) | -$247.48M(-57.2%) | -$1.76B(-242.8%) |
| Dec 2021 | - | -$578.38M(+95.8%) | $1.24B(-50.7%) |
| Sep 2021 | - | -$295.38M(-54.1%) | $2.51B(-18.1%) |
| Jun 2021 | - | -$643.58M(-123.4%) | $3.06B(-17.5%) |
| Mar 2021 | $3.71B(+38.1%) | $2.75B(+297.0%) | $3.71B(+186.9%) |
| Dec 2020 | - | $693.45M(+166.9%) | $1.29B(-1120.3%) |
| Sep 2020 | - | $259.79M(+4122.9%) | -$126.82M(-104.1%) |
| Jun 2020 | - | $6.15M(-98.2%) | $3.07B(+14.3%) |
| Mar 2020 | $2.69B(-110.5%) | $334.60M(-146.0%) | $2.69B(-130.2%) |
| Dec 2019 | - | -$727.37M(-121.0%) | -$8.91B(-60.4%) |
| Sep 2019 | - | $3.46B(-1013.8%) | -$22.48B(-12.9%) |
| Jun 2019 | - | -$378.52M(-96.6%) | -$25.80B(+0.9%) |
| Mar 2019 | -$25.58B(+2936.2%) | -$11.26B(-21.2%) | -$25.58B(+67.3%) |
| Dec 2018 | - | -$14.30B(<-9900.0%) | -$15.28B(+1327.4%) |
| Sep 2018 | - | $137.47M(-187.7%) | -$1.07B(-43.4%) |
| Jun 2018 | - | -$156.69M(-83.8%) | -$1.89B(+124.7%) |
| Mar 2018 | -$842.45M(-86.1%) | -$968.00M(+1058.6%) | -$842.45M(-84.9%) |
| Dec 2017 | - | -$83.55M(-87.8%) | -$5.57B(-3.0%) |
| Sep 2017 | - | -$684.96M(-176.6%) | -$5.75B(+12.3%) |
| Jun 2017 | - | $894.05M(-115.7%) | -$5.12B(-15.6%) |
| Mar 2017 | -$6.06B | -$5.70B(+2101.2%) | -$6.06B(+4138.0%) |
| Dec 2016 | - | -$258.79M(+361.1%) | -$143.07M(-61.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2016 | - | -$56.13M(+8.0%) | -$366.59M(-23.2%) |
| Jun 2016 | - | -$51.98M(-123.2%) | -$477.58M(-19.5%) |
| Mar 2016 | -$593.40M(-171.0%) | $223.83M(-146.4%) | -$593.40M(-33.1%) |
| Dec 2015 | - | -$482.31M(+188.6%) | -$886.37M(-447.2%) |
| Sep 2015 | - | -$167.11M(-0.4%) | $255.31M(-32.6%) |
| Jun 2015 | - | -$167.81M(+142.7%) | $378.73M(-54.7%) |
| Mar 2015 | $835.33M(-154.3%) | -$69.13M(-110.5%) | $835.33M(+5.3%) |
| Dec 2014 | - | $659.36M(-1609.1%) | $793.48M(-169.2%) |
| Sep 2014 | - | -$43.69M(-115.1%) | -$1.15B(+5.5%) |
| Jun 2014 | - | $288.79M(-360.2%) | -$1.09B(-29.4%) |
| Mar 2014 | -$1.54B(-3.0%) | -$110.98M(-91.3%) | -$1.54B(+7.8%) |
| Dec 2013 | - | -$1.28B(-7897.5%) | -$1.43B(+871.7%) |
| Sep 2013 | - | $16.42M(-110.1%) | -$146.88M(-10.1%) |
| Jun 2013 | - | -$163.30M(+672.5%) | -$163.30M(-85.8%) |
| Mar 2013 | -$1.59B(-88.6%) | - | - |
| Mar 2012 | -$13.86B(+1102.4%) | - | - |
| Mar 2011 | -$1.15B(-9.0%) | -$21.14M(-94.8%) | -$1.15B(-33.4%) |
| Dec 2010 | - | -$403.51M(-18.9%) | -$1.73B(+9.8%) |
| Sep 2010 | - | -$497.71M(+116.0%) | -$1.58B(+24.5%) |
| Jun 2010 | - | -$230.38M(-61.6%) | -$1.27B(-0.0%) |
| Mar 2010 | -$1.27B(-83.6%) | -$600.29M(+141.5%) | -$1.27B(+90.1%) |
| Dec 2009 | - | -$248.53M(+32.6%) | -$666.30M(+59.5%) |
| Sep 2009 | - | -$187.37M(-18.7%) | -$417.78M(+81.3%) |
| Jun 2009 | - | -$230.41M | -$230.41M |
| Mar 2009 | -$7.72B(-964.2%) | - | - |
| Mar 2008 | $892.88M(-10.3%) | - | - |
| Mar 2007 | $995.64M(+1614.5%) | - | - |
| Mar 2006 | $58.07M(-108.6%) | - | - |
| Mar 2005 | -$673.77M(-45.5%) | - | - |
| Mar 2004 | -$1.24B(-207.4%) | - | - |
| Mar 2003 | $1.15B(+14.8%) | - | - |
| Mar 2002 | $1.00B(-290.0%) | - | - |
| Mar 2001 | -$527.85M(+13.3%) | - | - |
| Mar 2000 | -$465.96M | - | - |
FAQ
- What is Takeda Pharmaceutical Company Limited annual cash flow from investing activities?
- What is the all time high annual CFI for Takeda Pharmaceutical Company Limited?
- What is Takeda Pharmaceutical Company Limited annual CFI year-on-year change?
- What is Takeda Pharmaceutical Company Limited quarterly cash flow from investing activities?
- What is the all time high quarterly CFI for Takeda Pharmaceutical Company Limited?
- What is Takeda Pharmaceutical Company Limited quarterly CFI year-on-year change?
- What is Takeda Pharmaceutical Company Limited TTM cash flow from investing activities?
- What is the all time high TTM CFI for Takeda Pharmaceutical Company Limited?
- What is Takeda Pharmaceutical Company Limited TTM CFI year-on-year change?
What is Takeda Pharmaceutical Company Limited annual cash flow from investing activities?
The current annual CFI of TAK is -$2.41B
What is the all time high annual CFI for Takeda Pharmaceutical Company Limited?
Takeda Pharmaceutical Company Limited all-time high annual cash flow from investing activities is $3.71B
What is Takeda Pharmaceutical Company Limited annual CFI year-on-year change?
Over the past year, TAK annual cash flow from investing activities has changed by +$804.67M (+25.03%)
What is Takeda Pharmaceutical Company Limited quarterly cash flow from investing activities?
The current quarterly CFI of TAK is -$132.38M
What is the all time high quarterly CFI for Takeda Pharmaceutical Company Limited?
Takeda Pharmaceutical Company Limited all-time high quarterly cash flow from investing activities is $3.46B
What is Takeda Pharmaceutical Company Limited quarterly CFI year-on-year change?
Over the past year, TAK quarterly cash flow from investing activities has changed by +$356.97M (+72.95%)
What is Takeda Pharmaceutical Company Limited TTM cash flow from investing activities?
The current TTM CFI of TAK is -$2.41B
What is the all time high TTM CFI for Takeda Pharmaceutical Company Limited?
Takeda Pharmaceutical Company Limited all-time high TTM cash flow from investing activities is $3.71B
What is Takeda Pharmaceutical Company Limited TTM CFI year-on-year change?
Over the past year, TAK TTM cash flow from investing activities has changed by +$804.67M (+25.03%)